Clinical Trial

Role of Screening With Coronary Computed Tomography Angiography in Primary Prevention of Coronary Heart Disease

Study acronym: RESPECT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to determine whether coronary computed tomography angiography (CCTA) -based coronary heart disease(CHD) prevention strategy will be superior to traditional CHD prevention strategy, in reducing the future risk of CHD which included myocardial infarction, angina, cardiac death, and an emergency/urgent coronary revascularisation procedure, in a community population aged 40 to 69 years with cardiovascular risk factors but no history of cardiovascular disease.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-06-21; most recent amendment 2022-07-03.
Trial Details
NCT Number NCT05431309
Lead Sponsor Jinling Hospital, China
Conditions Cardiovascular Primary Prevention Strategy
Enrollment 15,000 participants
Start Date 2022-07-01
Primary Completion 2028-11-30 (estimated)
Study Completion 2028-11-30 (estimated)
Updated on ClinicalTrials.gov 2022-07-07